Monitoring of immune response against brucella melitensis Rev- 1 vaccine following administration of some antibiotics [with 4 tables and 4 figures]
Assiut Veterinary Medical Journal. 2006; 52 (108): 211-230
Dans Anglais
| IMEMR
| ID: emr-135532
ABSTRACT
The humoral and cellular immune response in guinea pigs vaccinated with Rev-1 vaccine and simultaneously treated with antibiotics [oxytetracycline, streptomycin or enrofloxacin] or 4 weeks post-vaccination were evaluated in the present study. Groups vaccinated and simultaneously treated with oxytetracycline or 4 weeks post-vaccination showed delayed or abrupt reduction respectively in antibody production, lymphocyte transformation, phagocytic percent and intra-cellular killing one week post administration of this antibiotic while groups vaccinated and simultaneously treated with streptomycin or 4 weeks postúvaccination showed abrupt reduction in antibody titer and moderate reduction in phagocytic percent, intra-cellular killing and lymphocyte transformation. Treatment by enrofloxacin simultaneously with Brucella melitensis Rev-1 vaccine or at peak of vaccination [4 weeks postúvaccination] cause non-significant variation in both humoral and cellular immune response. Therefore oxytetracycline and streptomycin should not be recommended for animal treatment during exposure to Brucella melitensis Rev-1 vaccine. In contrast enrofloxacin exhibited a satisfactory margin of safety upon the humoral and cellular immune responses to Brucella melitensis Rev-1 vaccine
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Brucellose
/
Vaccins antibactériens
/
Antibactériens
Limites du sujet:
Animaux
langue:
Anglais
Texte intégral:
Assiut Vet. Med. J.
Année:
2006
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS